Abstract Myf-5 is a stage-dependent transcription factor associated with somitogenesis. To study its biological functions in zebrafish, we injected the Myf5-morpholinos ZMF-MO (antisense nucleotides 28 to 52) and ZMF-OTHER (antisense nucleotides 3 to 27) into zebrafish embryos to establish a myf-5 gene knockdown. No phenotypic abnormalities were observed following injection with 0.2 ng of ZMF-MO, but defects were displayed in 2 of 118 (1.7 %) surviving embryos injected with 1 ng ZMF-MO. Morphological defects became more severe with increased dosages: 105 of 270 (38.9 %) surviving embryos injected with 4.5 ng of ZMF-MO displayed such abnormalities as the absence of eyes or brains in addition to the following low-dosage defects in 24 hpf embryos: longitudinal yolk sacs, incomplete epiboly coverage, abnormal and suspended tail buds, diffused somite boundaries, and head shrinkage. Similar results were observed in the 4.5 ng ZMF-OTHER injection group. However, when fish were co-injected with 4.5 ng ZMF-MO and 4.5 ng myf-5 mRNA, abnormality rates decreased from 49.6 % to 5.5 %. Our results show that the brain krox20 gene was down-regulated at rhombomere 3; the pax2.1 gene was completely down-regulated; myoD was expressed normally; myogenin was substantially down-regulated in whole somites; and desmin was partly inhibited in newly forming somites. Our conclusion is that zebrafish Myf-5 may play important roles in brain formation and in the convergence and extension of shield epiblasts and tail buds during early embryogenesis, in addition to its well-understood role as a muscle regulatory factor in somites.
Introduction
In eukaryotic cells, muscle-specific gene transcription is controlled by a series of complex interactions among DNA-binding transcription factors and specific DNA recognition sequences. These factors can be categorized in terms of shared sequences and structural motifs, including the basic helix-loop-helix (bHLH) motif. Myogenesis involves several bHLH proteins, such as MyoD, MYF-5, Myogenin, and MRF4. The moleculars of myogenic regulatory factors (MRFs) have been identified in mammals (Buonanno et al., 1992) , birds (Saitoh et al., 1993) , frogs (Hopwood et al., 1991) , fish (Chen et al., 2000; 2002) , insects (Michelson et al., 1990) and nematodes (Krause et al., 1994) .
In mice, MyoD and Myf-5 play distinct roles in myogenesis. Cells in the epaxial myotome usually express myoD, while hypaxial myotomes express myf-5 (Rudnicki and Jaenisch, 1995) . Epaxial and hypaxial myotomes eventually differentiate into limbs and trunk muscles, respectively. Braun et al. (1992) reported that the targeted inactivation of myf-5 results in embryonic death; the mice embryos they studied were unable to breathe owing to the absence of ribs and sternum, even though normal muscle development was observed. In fish, the biological functions of Myf-5 have yet to be fully characterized. One exception is Neyt et al.'s (2000) use of zebrafish myoD as a molecular marker to demonstrate that teleost fin muscles in tetrapod species develop from migratory mesenchymal precursor cells that possess molecular and morphogenetic similarities with limb muscle precursors. However, no reports have been published to date on the targeted inactivation or gene knockdown of fish myf-5.
Recently, Chen et al. (2001) and Coutelle et al. (2001) reported that zebrafish myf-5 transcripts were detectable at 7.5 hours post-fertilization (hpf), increased substantially until 16 hpf, then gradually declined to undetectable levels by 26 hpf. They also found that during somitogenesis, zebrafish myf-5 transcripts were primarily found in somites and segmental plates. Prominent signals occurred transiently in adaxial cells in two parallel rows, but did not extend beyond positive-signal somites. Since adaxial cells and presomitic mesoderms are precursors of slow and fast muscles, respectively (Devoto et al., 1996) , we believe that zebrafish myf-5 may be involved in slow and fast muscle formation.
Morpholino, a nucleotide analogue, has been described by Nasevicus and Ekker (2000) as a powerful tool for gene function knockdown in zebrafish. To determine the biological functions of zebrafish myf-5, we injected Myf5-morpholino (myf5-MO) into single-cell zebrafish embryos and recorded the resulting myf-5 knockdown phenotypes. From our observations of zebrafish myf-5 morphants, we found that myf-5 is not only involved in myogenesis, but also plays important roles during early embryogenesis in the convergence and extension of shield epiblasts, as well as in tail bud and brain formation.
Methods
Fish AB strain Zebrafish were kept at a photoperiod of 14 h light/10 h dark at approximately 28.5 aeC. After fertilization, eggs were collected and cultured in an aquarium. Embryonic cleavage numbers were counted and somite formation observed with a light microscope to determine developmental stage (Kimmel et al., 1995) .
Preparation and microinjection of morpholino
Zebrafish myf5-morpholino (ZMF-MO: 5ø-TACGTCCATGAT-TGGTTTGGTGTTG-3ø) and myf5-morpholino-other (ZMF-OTHER: 5ø-AAGGTTTCTGAGTGGTGTGGTTGCA-3ø) were established based on zebrafish myf-5 cDNA complementary sequences from nucleotides (nt) 28 to 52 and 3 to 27, respectively (Gene Tools). Fluoresceinated chordin-MO (5ø-ATCCA-CAGCAGCCCTCCATCATCC-3ø) and standard control (nonspecific) MO (STD-MO) (5ø-CCTCTTACCTCAGTTA-CAATTTATA-3ø) were used as positive and negative controls, respectively (Gene Tools). All of the above were prepared at stocking concentrations of 1 mM and diluted with double-distilled water to concentrations of 10, 53, 133 and 250 mM (4.5 ng/embryo).
For our rescue experiment, we established the primers ZMFC1F (5ø-CCCAGTGCAACCACACCAC-3ø) and ZMFC1433R (5ø-CC-CGTTATTAAATAACACATTT-3ø) to amplify full-length zebrafish myf-5 cDNA by reverse transcription-polymerase chain reaction, using Superscript II (Gibco) and ExTaq DNA polymerase (TAKARA) as described in Chen et al. (2001) . The resulting PCR product was ligated to pGEMT-easy vector (Promega); the myf-5 cDNA in pT7-ZMF was driven by the T7 promoter. To construct pT7-EGFP, in which EGFP cDNA was also driven by the T7 promoter, primers GFP-F (5ø-ATGGTGAGCAAGGGCGAGGA-3ø) and GFP-R (5ø-CAGCTCGTCCATGCCATGTG-3ø) were synthesized and processed for PCR. For myf-5 or GFP mRNA preparation, approximately 5 mg of SpeI-digested pT7-ZMF or pT7-EGFP and mMESSAGE mMACHINETM (Ambion) were manufactured according to the supplier's directions. After synthesis, myf-5 and GFP mRNAs were diluted to working concentrations of 100, 500, 750 and 2000 ng/ml prior to each 2.3 nl injection.
Digoxigenin (DIG)-labeled riboprobe preparation
Approximately 5 mg each of plasmids containing cDNA of desmin (nt 1 to 1772) (Loh et al., 2000; Xu et al., 2000) , myoD (nt 216 to 951) , myogenin (nt 114 to 833) (Chen et al., 2000) , pax2.1 (nt 1214 to 1854) (Pfeffer et al., 1998) , and krox20 (nt 463 to 1021) (Oxtoby and Jowett, 1993) -all driven by a T7 promoter -were used as templates to prepare riboprobes (DIG RNA Labeling Kit, Rosche).
Whole-mount in situ hybridization
Normal and morphant embryos were collected at 24 hpf, fixed with 4 % paraformaldehyde for 4 h at 25 aeC, dechrionized, dehydrated with an ascending methanol series (25 %, 50 %, 75 % and 100 %), and stored in methanol at ª 20 aeC. The in situ hybridization of whole embryos was performed using DIG-labeled riboprobes of desmin, myoD, myogenin, pax2.1, and krox20 according to procedures described in Chen et al. (2001) , with some modifications. Embryos were permeabilized with acetone at ª 20 aeC, digested with 10 mg/ml proteinase K for 15 min, and prehybridized for at least 4 h. Hybridization took place at 70 aeC in the presence of approximately 10 ng DIG-labeled riboprobes for a minimum of 16 h. After washing, hybridized embryos were incubated overnight in a 1:10,000 dilution of alkaline phosphatase-conjugated anti-DIG antibody (Rosche) at 4 aeC. Excess antibodies were removed by progressively longer washings with 0.1 % Tween-20 in phosphate-buffered saline (10, 10, 10, 20, 30, and 60 min) . Color reactions (using nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate as substrates) were used to detect the hybridized myoD, desmin, myogenin, pax2.1, and krox20 mRNA transcripts.
Embedding and cryosectioning
Morphants and wild-type embryos were fixed with 4 % paraformaldehyde for 4 h at 25 aeC, dechrionized, mounted with 5 % sucrose containing 1.5 % agarose for 1 h, cut into cubes approximately 5 ¿ 5 ¿ 5mm and stored in 5 % sucrose at 4 aeC. All embryos were embedded using Cryomatrix (Shandon); cryosectioning (15 mm thick) was performed with a Microm Cryosector (Heidelberg).
Microscopy
All wide-type, morphant, and stained embryos were examined with a DMR microscope and photographed with a MPS 60 camera (both from Leica) using FUJI X-TRA 400 ASA film.
Results

Defective morphology in Myf5-MO-injected embryos
First, we injected a chordin antisense morpholino (chordin-MO) conjugated with fluorescein into zebrafish embryos as a positive control to observe specific phenotypes. Embryos injected with 4.5 ng of chordin-MO resulted in phenotypes marked by small heads, extremely large blood islands, abnormal tail fins, and U-shaped somites (Figs. 1a and 1c). They were similar to the chordin null-mutant embryos described by Hammerschmidt et al. (1996) , Fisher et al. (1997) , and Nasevicus and Ekker (2000) . Green signals were equally distributed, indicating chordin-MO stability in 24-hpf ( Fig.  1b) and 32-hpf embryos (Fig. 1d) . The percentages of abnormal phenotypes shown in parentheses were calculated from survival embryos.
. Severe defects in chordin-MO injection group including reduced head, extremely expanded blood island, abnormal tail fin and Ushaped somites.
No abnormal phenotypes were observed in negative control embryos injected with standard control/non-specific MO (STD-MO); survival was measured at 87.3 % (Table 1) . Likewise, no abnormal phenotypes were observed in mock control embryos injected with the same volume of double-distilled water, with an 86.5 % survival rate (Table 1 ). In the experimental group, all 150 sur- Fig. 2 Dynamic observation of ZMF-morphants. Wild-type em-coverage and suspended tail bud, respectively. Morphants were bryos (a-c, g) and ZMF-morphants (d-f, h-i) developed at 7.5 (a, classified into severe and mild defects based on morphological abd), 10 (b, e), 11.5 (c, f) and 24 hpf (g-i) were observed with a DMR normalities described in Methods. microscope. Arrow and arrowhead indicate incomplete epiboly viving embryos injected with 0.2 ng myf5-MO displayed normal embryonic development, but those injected with 1, 2.5 or 4.5 ng displayed abnormal phenotypes. The percentages of abnormal phenotypes shown in parentheses were calculated from survival embryos.
At 70 % epiboly (approximately 7.5 hpf), wide-type embryos displayed spherical shapes (Fig. 2a) , while morphants displayed longitudinal shapes and swelling yolk sacs (Fig. 2d) . At the end of the epibolic stage (∂ 9 hpf), myf5-MO-injected embryos developed bubble-like tail bud vesicles (Fig. 2e) , which eventually formed abnormal tail buds that failed to attach to the yolk at 11.5 hpf (Fig. 2f) . Some embryos injected with higher dosages of myf5-MO displayed abnormal somites at the middle segmental stage (18 -24 hpf). Those abnormalities included morphologically indistinct somite boundaries, lack of uniformly sized cell blocks, unclear tail buds, and unclear horizontal myosepta (Figs. 2h and 2i) . Abnormalities were categorized as mild or severe following morphological observations of myf5-MO-injected embryos at the end of the segmental stage (∂ 24 hpf). Mild defects mostly consisted of abnormal tail bud somites (Fig. 2i) , with a few scorpion-like tails also noted. Severe defects included the absence of eyes and abnormal heads (diminished telencephalons and mesencephalons) in addition to the mild defects just described (Fig. 2h) .
Dose-dependent Myf5-morphant abnormalities
Our results show that the frequency of phenotype abnormalities was myf5-MO dose-dependent (Table 1) . At 1 ng, 9.3 % (1.7 % mild, 7.6 % severe) of the surviving embryos displayed defects; at 2.5 ng, the percentage increased to 14.6 % (3.1 % mild, 11.5 % severe), and at 4.5 ng, the rate jumped to 54.5 % (15.6 % mild, 38.9 % severe). In addition, a sharp decrease in survival rate (from approximately 60 % to 25 %) was noted when embryos were treated with 9 ng myf5-MO: 56.4 % (31/55) of the surviving embryos showed arrested growth during the epibolic stage (data not shown).
Similar efficacies for two Myf5-MO types
We injected the morpholino ZMF-OTHER into embryos to gather further proof that the defective morphant phenotype was the result of the endogenous myf-5 knockdown. Abnormality rates resulting from 4.5 ng injections of ZMF-OTHER (14.3 % mild and 32.3 % severe) were similar to those caused by 4.5 ng injections of ZMF-MO (15.6 % mild and 38.9 % severe). The data suggest that the mild and severe defects were both the result of myf-5 knockdown phenotypes.
Co-injection of capped zebrafish myf-5 mRNA and ZMF-MO We found that incidences of severe and mild defects were reduced when embryos were co-injected with various dosages of capped myf-5 RNA and 4.5 ng of ZMF-MO. In the low-dosage-injection group (0.23 ng/embryo), the abnormality rate decreased from 49.6 % (15.8 % mild and 33.8 % severe) to 41.8 % (12.7 % mild and 29.1 % severe); in the high-dosage-injection group (4.5 ng/embryo), the abnormality rate decreased significantly to 5.5 % (5.5 % mild and 0 % severe) (Table 2 ). However, severe and mild defects increased slightly in control group embryos co-injected with 4.5 ng of capped GFP RNA and ZMF-MO (52.1 % total, 16.1 % mild and 35 % severe) ( Table 2 ). According to the data, the effect of ZMF-MO on knockdown myf-5 was both distinct and consistent.
Zebrafish Myf-5 and somitogenesis
To identify which muscle-specific genes were down-regulated in the 24-hpf ZMF morphants (resulting in somitepatterning defects), we performed whole-mount in situ hybridization with zebrafish myoD, myogenin, and desmin riboprobes. Our results show that myoD transcripts were strongly detectable in the somites and adaxial cells of wild-type embryos (Fig. 3a) . Myogenin expression patterns were similar to those for myoD (Fig. 3c) . In ZMF-morphants, myogenin transcripts were substantially down-regulated in the entire somite block (Fig.  3g ), but myoD transcripts were not (Fig. 3e) .
Our inspections of somite block cross-sections showed that myogenin transcripts appeared in the entire somite block, including slow-and fast-muscle pioneers in normal embryos (Fig. 3d ), but they were just barely detectable in morphants (Fig. 3h) . On the other hand, desmin transcripts were strongly detectable in whole somite blocks (anterior to posterior) as well as in slow-and fastmuscle pioneers, including adaxial cells (Figs. 3j and 3l) . In the oldest 24-hpf ZMF-morphant somites, desmin transcripts were clearly detectable, although with vague contours (Fig. 3k) . The only signs of desmin inhibition were noted in newly forming somites (Fig. 3k) . Note that all sections of myf5-morphants displayed a shrinkage notochord (Figs. 3f, 3h and 3i ), indicating that Myf-5 may be involved in notochord formation.
Zebrafish krox20 and pax2.1 transcripts Our results show that ZMF-MO treatment resulted in severe brain defects in ZMF-MO morphants. We used the same procedure just described with forebrain (pax2.1) and hindbrain (krox20) riboprobes to identify which portions of the brain in zebrafish were affected by ZMF-MO. In normal embryos, pax2.1 transcripts were detected in the forebrain, midbrain-hindbrain boundary (MHB), and optic stalk (Fig. 4c) ; krox20 transcripts were detected in rhombomeres 3 and 5 (r3 and r5) (Fig.  4a) . The krox20 transcripts were expressed normally at the r5 primordium, but down-regulated at r3 (Fig. 4b) . In contrast, pax2.1 transcripts were strongly detected in the optic primordium and MHB (Fig. 4c ), but were substantially down-regulated in the forebrains of mildly defective ZMF-morphants (Fig. 4d) .
Discussion
RNA-interference (RNAi) has been described as being very strong in Caenorhabditis elegans (Fire et al., 1998) and Drosophila (Misquitta and Paterson, 1999) ; Zhao et al. (2001) reported an unacceptably high level of RNAi in zebrafish. The use of a morpholino is currently considered the best antisense approach for in vivo studies of knockdown gene function in zebrafish (Nasevicius and Ekker, 2000; Ekker and Larson, 2001 ) for known (Dutton et al., 2001) as well as novel genes (Scholpp and Brand, 2001 ).
Epiblast convergence and extension
Data from our whole-mount in situ hybridization show that endogenous zebrafish myf-5 transcripts were first detected at 70 % epiboly, reached maximum expression at 16 hpf, and down-regulated at the end of the segmentation stage. ZMF-morphant defects were also first noticed at 70 % epiboly (Fig. 2d) ; a RT-PCR analysis revealed that endogenous zebrafish myf-5 transcripts were weakly detectable at 50 % epiboly (data not shown). Chen et al. (unpublished results) found that injection with a DNA construct containing zebrafish myf-5 upstream ª9977 to ª1 fused with a GFP reporter gene resulted in green signals becoming detectable in epiblasts at 50 % epiboly; by this point, epiblasts are undergoing convergence and extension, and cell lineages are becoming increasingly specific. Kiefer and Hauschka (2001) found that chicken myf-5 was expressed in epiblasts at 50 % epiboly and were expressed in some non-muscle mesodermic cells following wholemount in situ hybridization. In the present study, half of the surviving embryos in the 9 ng-injected myf5-MO group showed arrested growth during the epibolic stage. In the case of total myf-5 knockdown, embryos were unable to complete the epibolic stage and commence with segmentation. We therefore suggest that zebrafish Myf-5 has multiple functions, including epiblast migration and segmentation.
Myf-5 knockdown phenotypes
At 24 hpf, ZMF morphants displayed mild and severe defects. Both ZMF-MO (nt 28 to 52 of the antisense strand) and ZMF-OTHER (nt 3 to 27 of the antisense strand) were capable of causing such defects in 24-hpf morphants. No significant differences were noted in survival rates between embryos treated with either ZMF-MO (53.9 %) or ZMF-OTHER (57.1 %), but a slightly larger difference was noted in defective rates resulting from ZMF-MO treatment (54.5 %) compared to ZMF-OTHER treatment (46.6 %); this may be due to different blocking translation efficiencies between the two. Defect reduction attributed to the co-injection of ZMF-MO and capped myf-5 RNA was dose-dependent (Table 2) . Following injections of capped myf-5 RNA at dosages as high as 4.5 ng/embryo, morphant survival was measured at 43.1 % with a defect rate of only 5.5 %. However, injections of capped GFP RNA were incapable of reducing defective embryo rates (Table 2 ). These observations indicate that the mild and severe defects noted in this study were both distinct and consistent.
Comparing zebrafish ZMF-morphant and mice myf-5 knockout phenotypes Zebrafish embryos treated with myf-5 morpholino showed developmental defects, including epiblast migration retardment, abnormal somite patterning, brain deformation, and lethal effect of embryos. Severe rib defects and embryonic death were also noted in myf-5 knockout mice embryos, but defects in epiblast migration, somite patterning, and brain formation have not been reported. The greater number of abnormalities found in zebrafish treated with myf-5 morpholino may be due to a) a more concentrated effort to identify zebrafish morphants, and/or b) Myf-5 performs different biological functions in fish and mammalian systems.
Biological functions of Myf-5 during somitogenesis
In this study, zebrafish morphants showed abnormal muscle and defective somite patterning, suggesting that Myf-5 is essential to muscle development. To identify which muscle-specific factors are regulated by Myf-5 during somitogenesis, we searched for myoD, myogenin, and desmin expression patterns in wild-type embryos and ZMF-morphants. Myf-5, MyoD, and Myogenin are all classified as basic helix-loop-helix transcription factors, with MyoD being involved in myocyte determination and Myogenin being involved in myotube formation (Rudnicki and Jaenisch, 1995) . Desmin is a musclespecific intermediate filament protein that is regulated by Myf-5, MyoD, and Myogenin in mice (Li and Capetanaki, 1993; Rudnicki et al., 1993; Li et al., 1994) . We detected desmin transcripts in zebrafish in both the superficial muscle cells and the deeper parts of myotomes (Figs. 3i and 3j ). These were co-localized with myf-5, myoD, and myogenin, suggesting that desmin is also regulated by MRFs. According to Braun et al. (1992) and Rudnicki et al. (1992) , Myf-5 and MyoD compensate for each other in mice. Both teams of researchers also found normal myogenin and desmin transcription levels in myoD or myf-5 knockout mice. Hollenberg et al. (1993) demonstrated that myogenin is a direct transcriptional target of MyoD. Surprisingly, our results show that myoD transcripts were not affected in myf-5 knockdown zebrafish, but that myogenin and desmin transcripts were down-regulated in all somites and newly forming somites, respectively. Recently, Lindon et al. (2001) proposed that Myf-5 is a potent inducer of myogenin at high cell densities; there is also evidence that Myf-5 is fully capable of activating myogenin. We therefore suggest that myogenin is a transcriptional target found downstream of both myf-5 and myoD.
ZMF-morphants display brain abnormalities
Another possible explanation for brain abnormalities resulting from myf-5 knockdown zebrafish is reduced skeletal muscle. During nervous system development, motor neurons are believed to compete for specific skeletal muscle sites, with their long-term survival dependent upon receiving trophic support from the targeted muscle (Oppenheim, 1996) . In addition, Kablar and Rudnicki (1999) report that motor neurons in mice normally appear in the spinal cord, and that all somatic motor neurons in mutant mice are eliminated by apoptosis in myf5 ª/ª :myoD ª/ª double knockout mice. Sporle et al. (1996) described brain defects and strongly altered myf-5 expression patterns in open brain (opb) mutant mice. Combined, this evidence suggests that nervous development is intimately coupled with skeletal myogenesis. Clearly, myf-5 mRNAs exist in the central nervous system (CNS), but their biological functions during neuron or brain development require further study.
Finally, we found that reduced krox20 and pax2.1 expression domains in the anterior hindbrain region resulted in MHB and r3 hypoplasia. We therefore suggest that zebrafish Myf-5 may not be essential for hindbrain segmentation and specification, but may be essential for krox20 activation in the anterior hindbrain region.
Myf-5 may be involved in neurogenesis
Most studies on Myf-5 focus on myogenesis. However, Tajbakhsh and Buckingham (1995) detected myf-5 transcripts in mice brains, and therefore suggested that myf-5 might play an important role in brain development. Furthermore, Daubas et al. (2000) , Hadchouel et al. (2000) , and Carvajal et al. (2001) detected myf-5 mRNA in the CNS of mice, and therefore suggested that CNSspecific cis-elements may occur in the upstream -8.8 kb. These reports clearly show the presence of myf-5 tran-scripts in neurons, but their biological roles during neurogenesis remain unclear.
In this study, we observed that brain development was impeded in myf5-MO-treated embryos. According to Chen et al. (unpublished results) , a) the zebrafish ª2937 to ª290 (ª2937/ª290) myf-5 upstream regulatory sequence contains notochord-specific elements and b) in germ-line transmitted zebrafish, an myf-5 ª6212/ª1 segment fused with EGFP is capable of directing GFP expression in the spinal cord. Based on these observations, we propose the possible presence of a neuronspecific regulatory element within the zebrafish myf-5 gene. Zeller and Granato (1999) demonstrated that a distinct population of myotomal cells plays a pivotal role in the early migration of zebrafish motor axons. They also identified the diwanka gene as a somite-derived cue that is required for establishing an axonal path from the spinal cord to the somites. Their evidence provides insight into how neuronal and myotomal precursor cells are linked, and raise the possibility that the zebrafish myf-5 gene may follow the same pathway.
Comparing ZMF-morphants with known mutants Two types of somite-defective zebrafish mutants have been described and used for comparisons with myf5-morphants. The first, known as fss-type mutants, include defects associated with the segmentation and epithelialization of the somatic mesoderm: fused somites (fss), beamters (bea), deadly sevens (des) and after eights (aei) . In each of these, the segmental expression of MyoD in unsegmented regions is lost, but it is expressed throughout the somatic mesoderm . In the present study, the myoD transcripts were normally expressed in myf5-morphants (Fig. 3) , therefore we can rule out the possibility that myf5-morphants are fss-type mutants. Because they all result in U-shaped somites, the second group is known as you-type mutants; they include you (you), youtoo (yot), slow-muscle-omitted (smu), and sonic-you (syu) Schauerte et al., 1998; Barresi et al., 2000; Varga et al., 2001 ). While we noticed that the somite boundaries of myf5-morphants were missing, they could not be considered U-shaped (Fig. 2) .
In other words, the myf5-morphants in our study displayed somite patterning defects that are not phenotypically similar to either fss-or you-type mutants. This makes them similar to myf5-morphants with such brain mutations as no isthmus (noi) and white tail (wit); the former lacks MHB, while the latter has some characteristics of fss-type mutants in addition to brain and spinal cord deficiencies Jiang et al., 1996) . A search of current databases failed to identify mutants that are phenotypically similar to the myf5-morphants observed in this study. We found that myf-5 in knockdown zebrafish is lethal to embryos, in the same way that it is lethal to the embryos of knockout mice . These results indicate the importance of myf-5 to early embryonic development. They may also explain why such an upstream control gene as myf-5 does not present phenotypes that overlap with other genes that are involved in these development pathways.
Our conclusion is that even though Myf-5 is best known as a muscle regulatory factor in somites, zebrafish Myf-5 is involved in the convergence and extension of shield epiblasts, tail buds, and brain formation during early embryogenesis.
